|
|
| |
| Wolff-Parkinson-White Syndrome management in a pregnant woman
Download PDF
|
Z. Hayati, S. Jayi, Y. Belhaj, Fz. Fdili Alaoui, H. Chaara, Ma. Melhouf
|
Abstract:
Wolff-Parkinson-White syndrome (WPWS) is a rare condition affecting between 0.1% and 0.3% of the general population. It is characterized by the existence of one or more accessory nodal pathways that provide anatomical support for ventricular pre-excitation. Symptomatic patients may experience symptoms such as palpitations, and have an esteemed risk of sudden death of 0.25% per year or 3% to 4% over a lifetime. Findings on ECG are characteristic including a short PR interval and prolonged QRS with a delta wave in the presence of sinus rhythm. In this paper, we report a case of WPWS in a pregnant woman with brief literature review. Though this work, we aim to draw attention on pregnancy as an event that tends to uncover asymptomatic pre-excitation to tachyarrhythmias, and that complicates therapeutical management of this condition since the majority antiarrhythmics should be regarded as potentially toxic to the foetus. Indeed, it is recommended to convert supra-ventricular tachycardia trying, first, vagal manoeuvres. As a second-line option, certain drugs can be safely used in pregnant patients with the Adenosine being the drug of choice. Regarding the anaesthetic management of WPWS a pregnant patient posted for caesarean section, regional anaesthesia is preferred over general anaesthesia, and epidural anaesthesia is preferred to the spinal.
|
|
|
| | |